Disease anticipation in familial myeloproliferative neoplasms

Blood

Volumn 112, Issue 6, 2008, Pages 2587-2588

  Rumi, Elisa ^a   Passamonti, Francesco ^b   Picone, Cristina ^b   Delia Porta, Matteo Giovanni ^b   Pascutto, Cristiana ^b   Cazzola, Mario ^b   Lazzarino, Mario ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER RISK; FAMILIAL CANCER; FLOW CYTOMETRY; HUMAN; LETTER; MYELOID METAPLASIA; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROGENY; PROGNOSIS; TELOMERE; THROMBOCYTHEMIA; FAMILY HEALTH; GENETIC SUSCEPTIBILITY; GENETICS; MYELOPROLIFERATIVE DISORDER; NOTE; ONSET AGE;

AGE OF ONSET; ANTICIPATION, GENETIC; FAMILY HEALTH; HUMANS; MYELOPROLIFERATIVE DISORDERS;

EID: 55249127374     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-05-160739     Document Type: Letter

References (7)

1. Landgren O, Goldin LR, Kristinsson SY. Helgadottir EA. Samuelsson J. Bjorkholm M. Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliterative neoplasms in Sweden. Blood. 2008;112:2199-2204.
2. Pardanani A, Lasho T, McGlure R, Lacy M, Tefferi A. Discordant distribution of JAK2V617F mutation in siblings with familial myeloproliferative disorders. Blood. 2006;107:4572-4573.
3. Rumi E, Passamonti F, Delia Porta MG, et al. Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation. J Clin Oncol. 2007;25:5630-5635.
4. Bellanné-Chantelot C, Chaumarel I, Labopin M, et al. Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders. Blood. 2006;108:346-352.
5. Horwitz M. Goode EL. Jarvik GP. Anticipation in familial leukemia. Am J Hum Genet. 1996;59:990-998.
6. Goldin LR, Pfeiffer RM, Li X, Hemminki K. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood. 2004;104:1850-1854.
7. Daugherty SE, Pfeiffer RM, Mellemkhjaer L, Hemminki K, Goldin LR. No evidence for anticipation in lymphoproliferative tumors in populationbased samples. Cancer Epidemiol Biomarkers Prev. 2005;14: 1245-1250.